1. Home
  2. JSPR vs PFX Comparison

JSPR vs PFX Comparison

Compare JSPR & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPR
  • PFX
  • Stock Information
  • Founded
  • JSPR 2018
  • PFX 2010
  • Country
  • JSPR United States
  • PFX United States
  • Employees
  • JSPR N/A
  • PFX N/A
  • Industry
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • PFX Finance: Consumer Services
  • Sector
  • JSPR Health Care
  • PFX Finance
  • Exchange
  • JSPR Nasdaq
  • PFX Nasdaq
  • Market Cap
  • JSPR 85.8M
  • PFX 101.2M
  • IPO Year
  • JSPR N/A
  • PFX N/A
  • Fundamental
  • Price
  • JSPR $4.43
  • PFX $49.25
  • Analyst Decision
  • JSPR Strong Buy
  • PFX
  • Analyst Count
  • JSPR 10
  • PFX 0
  • Target Price
  • JSPR $62.50
  • PFX N/A
  • AVG Volume (30 Days)
  • JSPR 155.4K
  • PFX 749.0
  • Earning Date
  • JSPR 05-20-2025
  • PFX 05-06-2025
  • Dividend Yield
  • JSPR N/A
  • PFX 5.56%
  • EPS Growth
  • JSPR N/A
  • PFX N/A
  • EPS
  • JSPR N/A
  • PFX 5.09
  • Revenue
  • JSPR N/A
  • PFX $24,036,577.00
  • Revenue This Year
  • JSPR N/A
  • PFX $16.80
  • Revenue Next Year
  • JSPR N/A
  • PFX $0.74
  • P/E Ratio
  • JSPR N/A
  • PFX $9.68
  • Revenue Growth
  • JSPR N/A
  • PFX 15.02
  • 52 Week Low
  • JSPR $3.13
  • PFX $43.53
  • 52 Week High
  • JSPR $26.84
  • PFX $57.40
  • Technical
  • Relative Strength Index (RSI)
  • JSPR 44.42
  • PFX 36.35
  • Support Level
  • JSPR $4.27
  • PFX $48.99
  • Resistance Level
  • JSPR $5.67
  • PFX $51.08
  • Average True Range (ATR)
  • JSPR 0.44
  • PFX 0.27
  • MACD
  • JSPR 0.01
  • PFX -0.03
  • Stochastic Oscillator
  • JSPR 28.32
  • PFX 54.59

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

Share on Social Networks: